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STUDY METHODS
Monitoring by the Gauteng Department of Health (GDoH) 
of the uptake of PEP by rape survivors during the period 
30 June 2002 - 31 May 2003 found that just 16.2% 
of rape survivors provided with the drugs completed 
all 28 days of treatment.5  Concerned by this low rate, 
GDoH commissioned research from the Centre for the 
Study of Violence and Reconciliation (CSVR) (where the 
two authors were based at the time) to explore factors 
affecting adherence to PEP in the aftermath of rape. 
A number of different approaches were attempted 
to recruit rape survivors. Letters explaining the study 
purpose and requesting assistance with recruiting victims 
were sent to organisations that provide counselling to 
rape survivors. One PEP site in the province which kept 
records of patients’ contact details also provided us with 
a list of 20 names and telephone numbers (many of 
which however turned out to be incorrect). Ultimately, 
15 survivors were recruited either by health care staff or 
researchers for in-depth, semi-structured interviews. 
Another 52 rape victims aged 14 years and older were 
recruited by researchers based at three PEP facilities 
in the province, two located in greater Johannesburg 
and one on the East Rand. Selection of these sites was 
based on convenience, as well as the high number of 
rape survivors they treated. Over a period of 3 months, 
amounting to 74 days in total, researchers spent 
every Monday and Friday at the selected sites. While 
stationed there they approached rape patients to ask if 
they would be willing to take part in a short interview 
around their experience of taking PEP. Of the 60 patients 
approached, 8 declined to be interviewed. The 52 
patients participating in the study therefore represent 
87% of all victims aged 14 years and older attending 
these health facilities on Mondays and Fridays during 
this period. Information obtained from the short, face-
to-face standardised interviews was coded and captured 
for statistical analysis with SPSS. 
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Eleven years after it was first mooted in 1996, the Criminal Law (Sexual Offences and Related Matters) Amend-
ment Act (32 of 2007) came into effect in December 2007. Law-makers proudly lauded sections 28 and 29 of the 
Act, which set out how post-exposure prophylaxis (PEP) to prevent HIV infection should be made available to rape 
survivors.*  These clauses are, however, neither particularly novel nor innovative, Cabinet having already approved 
(in April 2002) the provision of antiretroviral drugs to prevent HIV infection following rape. 
Subsequent to Cabinet’s decision, a few studies were conducted examining various facets of providing PEP as part 
of a health response to rape.1-4  In theory, these findings should have provided legislators with some insight into 
what was required by rape survivors from a PEP service, particularly in relation to psycho-social support. This was 
not the case, as we will show in this article, which draws on unpublished findings from 67 interviews with rape 
survivors†  exploring their adherence to PEP.
*These clauses came into effect on 25 March 2008.
†We use the terms ‘patient’, ‘victim’ and ‘survivor’ interchangeably in this report. 
‘Victim’ is used to recognise that a violent crime has been inflicted upon someone, 
‘survivor’ to acknowledge the long-term work required to cope with rape, and ‘patient’ 
because rape survivors are also using a health service.
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Both interview schedules focused on the following key 
themes: patient knowledge of the drugs and their use; 
drug side-effects and their impact on patients; and 
support and counselling received by rape survivors after 
the rape. Interviews were analysed according to these 
key themes. 
The ethical challenges of obtaining consent from children 
to participate in research meant that they were excluded 
from the study, which therefore does not explore factors 
affecting adherence to PEP of children younger than 
14. Further, it was very difficult to recruit rape survivors 
who had defaulted on their treatment. Our findings are 
therefore more characteristic of women who adhere to 
their medication than of those who do not.  
RESULTS
DESCRIPTION OF OUR SAMPLE: PEP FACILITIES
Fifty-two respondents, comprising 48 women and 4 
men, were interviewed. Slightly under half of those 
interviewed were aged between 14 and 19 years (48%). 
Approximately 38% of patients were aged between 20 
and 29 years and 12% were between 30 and 39. The 
majority of patients had reported the incident to the 
police (96%) and most (88%) waited less than 6 hours 
before being taken to a hospital. Of the patients seen, 4 
were asked by hospital staff to first report the incident 
to the police before they could be treated – of these, 3 
did not want to do so.‡    
More than half of the patients (24 or 56%) for whom 
information was available were completing their second 
week of PEP, while 10 (23%) were in their third week of 
treatment. Six (14%) patients had completed their first 
week of PEP and 3 had just completed all 28 days.§ 
While pre-test counselling was conducted with three-
quarters of patients, only 58% received post-test 
counselling. Slightly more than one in three (19 or 37%) 
patients reported having missed pills at some point. In 
5 cases treatment was stopped because patients had 
defaulted. Of this group, 3 stopped because they had 
skipped a number of pills, while the other 2 stopped 
because of side-effects. 
IN-DEPTH INTERVIEWS
In-depth interviews were conducted with 15 survivors. 
The youngest rape survivor was 16 and the oldest 45, 
with most (9) being in their 20s. Four women were aged 
19 or younger at the time of the interview, while 2 were 
over 30. All said they completed the entire treatment 
regimen, with 2 reporting that they had missed taking 
pills – one because she forgot and the other because she 
tired of the pills. It is very likely that a third patient may 
also not have adhered to her PEP. This patient, although 
maintaining that she did not miss any pills, said she took 
her pills only once a day which suggests that she did not 
understand how to take her pills and is therefore very 
likely to have missed a number of doses. 
WOMEN’S KNOWLEDGE OF PEP
Women exhibited varying degrees of understanding of 
the treatment. Almost 9 in 10 (88%) of the PEP facility 
sample could not name the pills they had been given 
(although a small number thought they were taking 
nevirapine). Patients from one particular site, were 
however able to describe their pills accurately. 
Asked how many pills they were taking daily, responses 
varied from between 6 pills to 15 pills. (In terms of the 
regimen prescribed by GDoH at the time, the correct 
number of pills would have been 8.)¶  Approximately 1 
in 3 (33%) reported taking the incorrect number of pills. 
One patient, for example, had not clearly understood 
that she was meant to take both 3TC and AZT and was 
taking two pills from only one of the packets instead of 
one pill from each of the packets. 
One patient said the nurses did not explain to her how 
the pills needed to be taken. Another patient, thinking 
that the medication had only to be taken for a week, had 
stayed away from school for that week to ensure that 
she took her pills correctly and did not miss any doses. 
It was noticeable across the majority of interviews that 
patients did not know when the treatment was to end 
and were merely taking their medication from week to 
week with no clear understanding of when it would be 
completed. 
Women who participated in the in-depth interviews 
provided further insight into additional factors affecting 
their understanding of the drug regimen. At least 3 
patients maintained that they had been in no state to 
listen to instructions about the treatment. Only after they 
went home were they able to sit down and determine 
from the package inserts how the pills should be taken. 
Even if she explained, I wouldn’t remember. You 
know, when something like this happens, you think 
about other things. ‡The one patient who did want to lay charges struggled to find someone willing to 
take his report. He first went to Site 3 where he was told to go to the police station 
to make a statement. (Apparently no police were on duty at Site 3 on this particular 
occasion.) When he went to the station closest to where he lived, he was referred to 
the station closest to where the incident occurred. Concerned that time was running 
out, he went back to the clinic but was once again turned away. He went to another 
police station and was finally taken to Site 7. This patient spent about 12 hours trying 
to access a PEP service.
§In the case of 9 patients it was not clear how many weeks they had completed.
¶This included two AZT pills at 6-hourly intervals and one 3TC tablet at 12-hourly 
intervals over one 24-hour period. This regimen should be repeated over 28 days.
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No, I don’t remember them explaining. I know I just 
had to get them and go home and sleep. At that 
time, I don’t remember any explanations. 
Some women were actively engaged in a process of 
repressing their memory of the rape. They could not 
recall the date or month in which they were raped 
and remembered little of what had happened in the 
immediate aftermath. At least one stated that she was 
deliberately trying to forget the entire experience.
SIDE-EFFECTS
Some 9 in 10 patients (46 or 88%) experienced side-
effects, but only 14 (27%) told staff about these side-
effects. Having been told to expect side-effects, they did 
not think they should mention them to the nurse. Of the 
14 who reported the side-effects, 92% reported that 
nothing changed in their treatment. Only one patient 
was given other medication to help address the side-
effects. 
The most common side-effects were nausea and 
vomiting, with 34 survivors (65%) complaining of these. 
Tiredness and drowsiness were reported by 18 survivors 
(35%). Other side-effects included feeling dizzy and 
weak (14 or 27%), stomach upsets and soreness (10 or 
19%) and headaches (7 or 13%). Twelve (23%) patients 
reported changes in their appetite, 9 losing their appetite 
while 3 thought their appetite increased. One reported 
painful lungs and another said she developed a rash 
around her genital area. Two reported changes in their 
periods, but this is likely to have been the result of the 
other medication they were provided with. Of the rape 
survivors 85% experienced more than one side-effect.
Like those women interviewed at the PEP facilities, almost 
all interviewees (14) experienced side-effects, with 12 
suffering multiple side-effects. The presence of these 
side-effects tempted patients to stop their pills. One 
woman commented, ‘The first week of tablets I vomited 
the whole week. I did not even go to work’. The degree to 
which these side-effects incapacitated survivors varied, 
some maintaining that it was constant throughout the 
28 days and others saying that they experienced side-
effects in the first week or two only. 
The two rape survivors who did alert staff to the 
unpleasantness of their side-effects were not treated 
by the health facility but told to get medication from a 
pharmacy instead. One of these patients stated that she 
was not able to afford this medication and would have 
appreciated the hospital providing her with treatment. 
A third patient sought help for her side-effects from a 
private doctor. 
Patients usually coped with the side-effects by changing 
their eating and drinking patterns, typically timing their 
pills with their meals (a particular challenge for those 
who had lost their appetite). One took sweets with her 
pills while 3 others added various types of drinks – tea, 
soda water and ginger ale – to their diets to help deal 
with the side-effects. A few patients stopped taking 
their pills until some of the side-effects had subsided 
and then started again.  
FACTORS AFFECTING ADHERENCE TO PEP
Slightly more than 1 in 3 (37%) patients interviewed at 
PEP facilities reported having missed pills at some point. 
Forgetfulness was the reason most commonly cited 
for missing pills (6); this was linked to the next most 
common reason for skipping, i.e. patients not being at 
home when they were meant to take the pills (5). Four 
patients skipped pills to cope with the side-effects (one 
patient specifically excluding AZT), and one patient said 
she did not understand how the pills were supposed to 
be taken. Another reported that she could not get to the 
clinic to get more pills because she was at school.  
More than half of patients (28 or 54%) interviewed at 
PEP facilities identified side-effects as the factor that 
made it difficult for them to take the pills. Two women 
who participated in the in-depth interviews provide very 
different reasons why side-effects could cause patients 
to default. One, a 17-year-old scholar, commented:
The smell was just making me sick when I open the 
container. And every time I walk into my bedroom I 
would just smell it and that was making me sick. … 
I vomited and then I saw the pills there and I was 
like, ‘Oh no’ … I just got this disgust feeling of ‘No, 
I’m not going to take this any more.’ 
Because she had only 3 days left of her medication, she 
justified defaulting on the basis that she was very close 
to the end of her pill regimen and it would make little 
difference if she stopped now.
The other woman did not experience any side-effects in 
taking PEP, but having been told to expect side-effects, 
she assumed that their absence meant she was ‘cured’ of 
HIV and could therefore stop taking the drugs. A family 
member persuaded her to continue. 
Over and above side-effects, there were other factors 
that made it difficult for patients to take the pills. These 
included not liking the taste and smell of the pills; 
finding the sheer number of pills overwhelming; and the 
role they played in reminding patients of the incident. 
Thirteen patients said they did not have any difficulties 
taking the pills.  
Fear also emerged as a barrier to accessing PEP facilities, 
with a small number of women being frightened of 
leaving home to come to the clinic, particularly if the 
rapist/s were still at large. 
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When asked what helped them take their pills, 15 patients 
cited fear of contracting HIV as their motivating factor, 
while 11 maintained that family members reminding 
them made it easy. One interviewee stated that she 
reminded herself by setting her alarm clock when pills 
were meant to be taken, while 2 said nothing made it 
easier to take their pills. 
COUNSELLING AND SUPPORT
Almost all of those interviewed reported having told 
someone about the need to take the pills. In all of these 
cases the survivor received support from those they had 
told, which included family members, school teachers, 
workmates and friends. 
In one case where it appeared that the survivor’s parents 
blamed her for the rape, her sister assisted her to take 
her medication and often kept her pills for her. Another 
patient was hiding her pills because she had not told her 
parents of the rape out of fear of their reaction. 
Of the 52 patients interviewed, more than half (56%) had 
not been for any counselling. Patients at one particular 
site were most likely to have gone for counselling, mainly 
because there was a social worker at the facility. 
At the time of the study, patients were collecting their 
PEP from the facility on a weekly basis. During the in-
depth interviews, we asked survivors what they thought 
of this practice. With the exception of 3 rape survivors, 
most women were in favour of the weekly visits to the 
hospital for repeats, saying they encouraged them to 
continue taking their pills and provided an opportunity 
for their health to be monitored. These patients spoke of 
the psychological benefits of weekly visits to the clinic: 
You actually hope that by going there they will 
make you feel better about the problems you have 
– I think every week – because somehow it gives 
you hope going back there, and I thought it would 
make me feel better. 
One patient remarked that she was very emotional 
when she visited the clinic. Staff at the site were helpful, 
allowing her to cry and encouraging her to continue 
taking the pills. Another patient thought that staff 
counselling and talking to patients when they came for 
weekly visits was essential in helping them move on. 
Survivors stressed the importance of ongoing support 
and counselling and suggested that more referrals be 
made to counselling services. 
DISCUSSION
The interviews suggest that adhering to PEP is neither 
pleasant nor easy, and almost all of the rape survivors 
in this study required encouragement and support from 
health workers, family, friends and counsellors to do 
so. The interviews also illustrate how the trauma and 
distress caused by rape may affect adherence. Shock in 
the immediate aftermath of the event made it impossible 
for some women to recall what they had been told about 
PEP, while for others the drugs brought back unpleasant 
memories of the rape. Collecting PEP was also a fear-
filled exercise for some women. The in-depth interviews 
also suggest that when women went to health facilities, 
they were not only hoping to be treated in relation to 
PEP but also wanted to be helped with their distress 
and trauma. However, it would seem that the health 
response to these survivors was primarily being shaped 
by concerns around HIV, rather than their health care 
needs globally after the rape. 
Other studies have also highlighted counselling as 
an important component of a PEP service. One study 
investigated, from rape survivors’ perspectives, what 
services they consider most necessary. They found that 
respondents most valued the availability of HIV post-
exposure prophylaxis (with an HIV test) and having 
a sensitive health care provider who could provide 
counselling. They did not make choices based on travel 
time. The study suggests that patients are willing to trade 
off access to services (time travelled) for attributes such 
as HIV PEP, counselling, and a thorough examination.2 
The second study sought to develop an integrated model 
for integrated post-rape care and HIV PEP. Among other 
things, the intervention focused on expanding the 
role of nurses in the management of sexual assault by 
equipping them to document the rape history, provide 
acute trauma debriefing, provide a stat dose of PEP, take 
a pregnancy test, dispense the treatment package and 
provide medication counselling and make follow-up 
referrals. Whereas 61.5% of patients found the health 
care worker’s counselling helpful before the intervention, 
this number rose to 98.5% after intervention. PEP 
completion rates rose from 20.0% to 58.3% (although 
this was not due to the counselling alone).6 
CONCLUSION
Taken together, these three studies highlight counselling, 
or emotional and psychological support, as an integral 
component of a PEP service. Yet in finalising the Sexual 
Offences Act, counselling services turned out to be what 
legislators were unwilling to provide. The South African 
Law Commission, in its discussion paper on reforming 
the law applicable to sexual offences, recommended 
that the State provide psychosocial support and health 
care to victims of sexual offences.7 The Department of 
Justice and Constitutional Development did not accept 
this recommendation and excluded it from the Sexual 
Offences Bill introduced to Parliament in 2003. Removal 
of this clause minimises the seriousness of the physical 
and psychosocial trauma resulting from sexual offences 
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and ignores the currently differential availability of, and 
access to, services for wealthy and poor South Africans.
It is not necessary to pass legislation before psychosocial 
services can be provided to rape survivors. But in passing 
legislation which treated PEP as rape victims’ only health 
service need, legislators reinforced the separation of 
HIV from other health concerns, rather than seeing 
them as intimately intertwined, and elevated HIV over 
other health concerns. It is to be hoped that health care 
workers do not repeat this error. 
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Course Name Course Dates City/town Cost (VAT Incl)
HIV/AIDS Management Course: Given the current state of knowledge on HIV/AIDS management and the fact that
anti-retroviral therapy is becoming more affordable, it is now feasible to approach HIV/AIDS as a chronic medical
condition. This course will empower clinicians to adequately manage patients with HIV and or AIDS.
HIV/AIDS Management Course 27-28 Feb 2009 Cape Town R 3,000.00
HIV/AIDS Management Course 28 -29 March 2009 Durban R 3,000.00
HIV/AIDS Management Course 3-5 April 2009 JHB R 3,000.00
HIV/AIDS Management Course 13-14 June 2009 JHB R 3,000.00
HIV/AIDS Management Course 8-9 Aug 2009 Pretoria R 3,000.00
HIV/AIDS Management Course 25-27 Sept 2009 Cape Town R 3,000.00
HIV/AIDS Management Course 2-4 Oct 2009 Durban R 3,000.00
HIV/AIDS Management Course 9-11 Oct 2009 Free State R 3,000.00
HIV/AIDS Management Course 21-22 Nov 2009 Mpumalanga R 3,000.00
HIV/AIDS Management Course 1-3 Dec 2009 Pta R 3,000.00
HIV/AIDS Management Course 3-5 Dec 2009 Cape Town R 3,000.00
HIV/AIDS Refresher Seminar: HIV/AIDS is an ever-evolving discipline and with ARV drugs becoming more
affordable, health professionals therefore need to stay abreast with the latest developments. The Foundation for
Professional Development, in association with the Southern African HIV Clinician Society, developed this one-day
refresher seminar which is targeted at alumni who successfully completed the 3-Day HIV/AIDS Management Course.
We encourage all our alumni who completed the 3-day course to enrol on this refresher course so that they have
access to the most recent evidence-based information on drugs and the management of HIV/AIDS patients.
HIV/AIDS Refresher Seminar 28-Feb-09 JHB R 1,300.00
HIV/AIDS Refresher Seminar 11-Mar JHB R 1,300.00
HIV/AIDS Refresher Seminar 30-May-09 Durban R 1,300.00
HIV/AIDS Refresher Seminar 5-Nov-09 Cape Town R 1,300.00
HIV/AIDS Refresher Seminar 1-Dec-09 Durban R 1,300.00
Paediatric HIV/AIDS Management Course: Children with HIV/AIDS are dying unnecessarily because of a lack of
access to ARV treatment. The problems arise mainly from a lack of cheap feasible diagnostic tests for children under
18 months, lack of trained health personnel and the affordable child-friendly ARV drugs. Simplified treatment
guidelines coupled with a range of fixed-dose combinations of ARVs that require only one or two pills twice a day
make it easier to treat HIV/AIDS in adults, but development of simplified drugs for children lags behind. Despite WHO
simplified treatment guidelines that specify which drugs to use in children, countries have difficulty in getting simple
and affordable combinations of the drugs. Two generic fixed-dose combinations should enter clinical trails this year,
and there are frighteningly few second-line ARV drugs available for children in countries with large numbers of infected
children.
Paediatric HIV/AIDS Management Course 13-15 March 2009 Pretoria R 3,200.00
Paediatric HIV/AIDS Management Course 27-29 April 2009 CT R 3,200.00
Paediatric HIV/AIDS Management Course 8-10 May 2009 CT R 3,200.00
Paediatric HIV/AIDS Management Course 2-4 Oct 2009 PTA R 3,200.00
Clinical and Ethical Refresher Course for GP's: The Clinical and Ethical Refresher Seminar is designed to offer a
unique learning experience by combining clinical and ethical issues in an effort to help general practitioners to update
their skills and knowledge in specific areas. Most healthcare professionals have limited time available to attend clinical
programmes. Furthermore, attending individual courses is costly and may be time consuming. The FPD Summer
Academy therefore intends to offer healthcare professionals an opportunity to get away, save time and money, gain
CPD points for attending this learning experience and get the best of what FPD has to offer.
Clinical and Ethical Refresher Course for GPs 30/5-1/6 2009 Midrand R 3,140.00
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